Theravance Biopharma, Inc. Weighted Average Number of Shares, Restricted Stock
Theravance Biopharma, Inc. (TBPH) reported Weighted Average Number of Shares, Restricted Stock of 492.00 thousand shares for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesRestrictedStock · last filed 2014-08-14
- Theravance Biopharma, Inc. weighted average number of shares, restricted stock for the quarter ending 2014-06-30 was 492.00K shares, a 0.00% change year-over-year.
- Theravance Biopharma, Inc. weighted average number of shares, restricted stock for the quarter ending 2013-06-30 was 492.00K shares.
| Period end | Weighted Average Number of Shares, Restricted Stock 3 month | Weighted Average Number of Shares, Restricted Stock 6 month |
|---|---|---|
| 2014-06-30 | 492.00K shares 10-Q · filed 2014-08-14 | 492.00K shares 10-Q · filed 2014-08-14 |
| 2013-06-30 | 492.00K shares 10-Q · filed 2014-08-14 | 492.00K shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |